EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Burden of Esophageal Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction Until 2036: An Analysis of the Global Burden of Diseases Study 2021

Tianhao Guo iD, Yumo Yuan iD, Tingting Zhou iD, Yifan Hui iD, Yuhan Wang, Wenjian Zhu iD, Weixing Shen, Liu Li, Yu Yang, Haibo Cheng iD

Thoracic Cancer · 2025

DOI: 10.1111/1759-7714.70045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thoracic Cancer, 2025. Verfasst von Tianhao Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health and Regimen, Jiangsu Open University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Global Burden of Disease. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, National Key R&D Program of China, NATCM's Project of High-level Construction of Key TCM Disciplines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In 2022, esophageal cancer (EC) was the eleventh most frequently diagnosed cancer and the seventh leading cause of cancer‐related deaths worldwide. Nonetheless, the prevalence and burden of EC in Asian countries have been little studied. This study investigated the prevalence, incidence, and burden of EC in five East Asian countries from 1990 to 2021.

Methods

We retrieved data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 on the prevalence, incidence, mortality, years lived with disability (YLDs), years of life lost (YLLs), and disability‐adjusted life years (DALYs) associated with EC in five East Asian countries from 1990 to 2021. The epidemiological characteristics of EC were analyzed by joinpoint regression, age‐period‐cohort analysis, and decomposition analysis. The burden of EC until 2036 was estimated using autoregressive integrated moving average and Bayesian age‐period‐cohort models.

Results

Among these East Asian countries, China had the highest incidence, prevalence, mortality rates, YLLs, YLDs, and DALYs in 1990 and 2021. China and Mongolia exhibited the highest age‐standardized incidence rate, age‐standardized mortality rate, age‐standardized prevalence rate, age‐standardized YLDs rate, age‐standardized YLLs rate, and age‐standardized DALYs rate from 1990 to 2036. The age group with the highest prevalence rate, incidence rate, mortality rate, YLDs rate, YLLs rate, and DALYs rate in these countries was ≥ 55 years. The prevalence and incidence rates in the five countries were influenced by aging and were higher than the global average.

Conclusions

The burden of EC in five East Asian countries was high over the past three decades, particularly among older adults. EC is a significant public health problem in these countries, particularly because of the large population base and aging demographics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsGlobal Burden of DiseaseHumansMaleFemaleMiddle AgedIncidenceAsia, EasternPrevalenceAgedDisability-Adjusted Life YearsAdultCost of IllnessQuality-Adjusted Life YearsRisk FactorsEast Asian People

Stichwörter der Autor:innen

age‐period‐cohort analysisdisease burdenepidemiological studyesophageal cancerglobal burden of disease studyjoinpoint regression analysisprediction models

Autor:innen und Institutionen

  • Institute of Health and Regimen, Jiangsu Open University, Nanjing, Jiangsu, China.
  • Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing, Jiangsu, China.
  • The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • School of Elderly Care Services and Management, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
  • Wangjing Hospital of the China Academy of Chinese Medical Sciences, Beijing, China.
  • Department of Surgical Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

ORCID-Profile: Tianhao Guo, Yumo Yuan, Tingting Zhou, Yifan Hui, Wenjian Zhu, Haibo Cheng

Förderung

  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • National Key R&D Program of China
  • NATCM's Project of High-level Construction of Key TCM Disciplines
  • Qing Lan Project of Jiangsu Higher Education Institutions
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • General Project of Universities' Philosophy and Social Science in Jiangsu Province
  • National Key Research and Development Program of China

Zitieren

APA

Guo, T., Yuan, Y., Zhou, T., Hui, Y., Wang, Y., Zhu, W., Shen, W., Li, L., Yang, Y., & Cheng, H. (2025). The Burden of Esophageal Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction Until 2036: An Analysis of the Global Burden of Diseases Study 2021. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70045

Vancouver

Guo T, Yuan Y, Zhou T, Hui Y, Wang Y, Zhu W, et al. The Burden of Esophageal Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction Until 2036: An Analysis of the Global Burden of Diseases Study 2021. Thoracic Cancer. 2025. doi:10.1111/1759-7714.70045

BibTeX
@article{Guo2025,
  author = {Guo, Tianhao and Yuan, Yumo and Zhou, Tingting and Hui, Yifan and Wang, Yuhan and Zhu, Wenjian and Shen, Weixing and Li, Liu and Yang, Yu and Cheng, Haibo},
  title = {The Burden of Esophageal Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction Until 2036: An Analysis of the Global Burden of Diseases Study 2021},
  journal = {Thoracic Cancer},
  year = {2025},
  doi = {10.1111/1759-7714.70045}
}
Kostenlos starten →